Monday, September 25, 1995
Therexsys: Regulated expression
As with most novel technologies, the doing is in the details. That is proving to be true in gene therapy, which consists of more than just plunking a gene in a vector and wishing it bon voyage. An important component of the package required to deliver genes successfully is the regulation of expression of the genes in target cells.
Therexsys Ltd.'s technology is based on second-generation nonviral receptor-mediated delivery systems to deliver genes to target cells, combined with its ability to regulate expression of genes using cell-specific control elements called locus control regions (LCRs).